who: Alexey Goltsov from the Centre for Research in Informatics and Systems Pathology (CRISP), University of Abertay, UK have published the article: Customizing the therapeutic response of signaling networks to promote antitumor responses by drug combinations, in the Journal: (JOURNAL)
what: To help overcome these complexities and challenges, the authors propose a method for the in_vitro/in_vivo/in silico validation of the targets of drug combinations and quantitative estimation of the perturbations induced by drugs in SNs. Using sensitivity analysis (SA) of this signaling response, the authors show that inhibition of various targets by the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.
